Highbridge Capital Management’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-14,200
| Closed | -$39K | – | 1306 |
|
|
2017
Q4 | $39K | Sell |
14,200
-118,277
| -89% | -$325K | ﹤0.01% | 740 |
|
|
2017
Q3 | $449K | Buy |
132,477
+112,477
| +562% | +$381K | 0.01% | 552 |
|
|
2017
Q2 | $49K | Buy |
+20,000
| New | +$49K | ﹤0.01% | 794 |
|
|
2016
Q4 | – | Sell |
-474,610
| Closed | -$1.59M | – | 1523 |
|
|
2016
Q3 | $1.59M | Buy |
+474,610
| New | +$1.59M | 0.03% | 423 |
|
|
2016
Q1 | – | Sell |
-132,772
| Closed | -$470K | – | 1392 |
|
|
2015
Q4 | $470K | Buy |
+132,772
| New | +$470K | 0.01% | 570 |
|
|
2015
Q2 | – | Sell |
-481,528
| Closed | -$3.39M | – | 1298 |
|
|
2015
Q1 | $3.39M | Sell |
481,528
-33,077
| -6% | -$233K | 0.05% | 331 |
|
|
2014
Q4 | $3.97M | Sell |
514,605
-219,786
| -30% | -$1.69M | 0.05% | 294 |
|
|
2014
Q3 | $5.49M | Buy |
+734,391
| New | +$5.49M | 0.07% | 265 |
|